146 related articles for article (PubMed ID: 34188925)
1. Transient disappearance of CD19
Barnabei R; Di Michele G; Cellini A; Amicosante G; Perilli M; Bellio P; Piccirilli A; Celenza G
Clin Case Rep; 2021 Jun; 9(6):e04238. PubMed ID: 34188925
[TBL] [Abstract][Full Text] [Related]
2. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
3. [CD43 in B-cell chronic lymphocytic leukemia].
Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.
Kay NE; Peterson L
Leuk Lymphoma; 1991; 5(1):49-55. PubMed ID: 27463209
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.
Ghia P; Prato G; Scielzo C; Stella S; Geuna M; Guida G; Caligaris-Cappio F
Blood; 2004 Mar; 103(6):2337-42. PubMed ID: 14630808
[TBL] [Abstract][Full Text] [Related]
7. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
9. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
[TBL] [Abstract][Full Text] [Related]
10. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
12. Biological Features of CD5+ CD19+ B1 Cell and Natural IgM (VH4-34) in Chronic Lymphocytic Leukemia vs. Multiple Sclerosis.
Pezeshki S; Jazayeri MH; Chahardouli B; Tajik N; Nabavi SM; Akbarzadeh M
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):670-676. PubMed ID: 36640058
[TBL] [Abstract][Full Text] [Related]
13. Unexpected CD5
Mazzarello AN; Koroveshi B; Guardo D; Lanza L; Ghiotto F; Bruno S; Cappelli E
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769644
[TBL] [Abstract][Full Text] [Related]
14. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
15. Chemokine Receptors CCR1 and CCR2 on Peripheral Blood Mononuclear Cells of Newly Diagnosed Patients with the CD38-Positive Chronic Lymphocytic Leukemia.
Kholodnyuk I; Rivkina A; Hippe L; Svirskis S; Kozireva S; Ventina I; Spaka I; Soloveichika M; Pavlova J; Murovska M; Lejniece S
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708233
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
17. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia with low lymphocyte count.
Batata A; Shen B
Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
Wang C; Amato D; Rabah R; Zheng J; Fernandes B
Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
Gupta R; Jain P; Deo SV; Sharma A
Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
